How much weight will you lose on 0.25mg Wegovy — and what does that mean for cost?

Is 0.25mg Wegovy supposed to cause weight loss?

This is probably the most common misconception about Wegovy, and it is worth clearing up gently: the 0.25mg dose is a tolerability step. Novo Nordisk and the prescribing guidance both describe it as a starter dose specifically designed to reduce the nausea and digestive discomfort that semaglutide can cause when introduced too quickly. The body needs a few weeks to adapt to a GLP-1 receptor agonist, and starting low is how that happens without unnecessary side effects.

So if you are at the 0.25mg stage and the scales have not moved, you are not doing anything wrong. The medicine is behaving exactly as it should. What to realistically expect at this dose is modest digestive adjustment, perhaps a slight reduction in appetite for some people, but not the meaningful weight reduction that comes later. The dose escalates roughly every four weeks, guided by the prescriber, moving through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance level, and there is now a licensed 7.2mg dose approved by the MHRA in April 2026 for adults with a BMI of 30 or above. If you are curious about how much weight you can expect to lose on Wegovy overall, that picture belongs to the maintenance phase of treatment, not the first pen. You can also explore how much weight loss is realistic specifically on the 0.25mg starting dose, which puts the early stage of treatment into helpful context.

A useful reference for the full licensed pathway and what each phase involves is the NHS patient information page on semaglutide, which sets out how the titration schedule works in plain terms.

How does private Wegovy pricing work across the treatment journey?

Because 0.25mg is a starter dose and the programme extends across several months before reaching maintenance, the cost of Wegovy in the UK should really be understood as a monthly commitment rather than a one-pen figure. UK private pricing varies between providers and by dose, the dose you are on at any given point determines what you pay that month. As a point of honest market context: Eli Lilly's published list-price increase for Mounjaro in September 2025 shifted the broader private weight-medicine market, and Wegovy pricing reflects similar dynamics. Reported private Wegovy prices in the UK have typically ranged roughly £149 to £375 per month depending on dose and provider, though these figures change and should always be checked directly with the pharmacy.

What headline prices sometimes leave out matters here. A low advertised figure may exclude the clinical consultation fee, the prescription charge, and the delivery cost, all of which some providers charge separately. Aftercare support between doses is often not included either. A fuller breakdown of what Wegovy costs in the UK and what those prices typically do and do not cover is worth reading before you compare options.

At nume, one price covers everything: the consultation, the prescription, the medicine, and free next-working-day delivery by DPD. We are not the cheapest option available, and that is a deliberate choice. The margin that a very low price removes is often the clinical oversight and aftercare that make treatment safer and more likely to work.

Why is cheapest the wrong question to ask about a prescription medicine?

Wegovy is a prescription-only medicine. That legal status exists for a reason, it requires a qualified prescriber to assess whether it is appropriate for you, at what dose, and whether anything in your medical history or current medications changes that picture. Many people also want to understand how much Wegovy slows down digestion, which is directly relevant to the side-effect profile your prescriber needs to discuss with you. The MHRA's Drug Safety Update communications on GLP-1 medicines have highlighted real risks, including acute pancreatitis, that require clinical awareness on the prescriber's side and clear guidance on the patient's.

When an online price looks unusually low, it is worth asking what has been removed to reach it. The MHRA has warned repeatedly about fake weight-loss pens being sold without a prescription via social media and unverified websites; in 2025, around 20 million doses of illegally traded weight-loss medicines were seized, with a street value near £45 million. That is not a hypothetical risk. Verifying that any pharmacy you use is GPhC-registered takes about thirty seconds on the GPhC register, and it is the single most important check you can do. Legitimate supply, genuine clinical assessment, and a prescriber who actually reads your consultation: these are the things that make treatment both safe and effective. Price is a reasonable thing to consider. It is just not the measure that keeps you well.

If you are ready to find out whether Wegovy is right for you, the free consultation at nume is the place to start. A real prescriber reviews your answers the same day. You can also read more about Wegovy and how it works before you decide, including what weight loss to expect when you reach the 1mg dose, or learn more about who we are and how our pharmacy operates.